1. Posaconazole.
- Author
-
Bhattacharya, M., Rajeshwari, K., and Dhingra, B.
- Subjects
- *
ANTIFUNGAL agents , *CLINICAL drug trials - Abstract
Posaconazole is a novel second-generation Triazole oral antifungal agent. It is highly effective in the prophylaxis of invasive fungal infections in immunocompromised patients. It is used as a first-line agent as well as for salvage therapy in invasive fungal infections including aspergillosis, oropharyngeal and esophageal candidiasis. It has a good adverse effect profile. With the rising incidence of invasive fungal infections due to the HIV pandemic and medical advancements in transplantation and cancer therapy, these features make posaconazole a valuable addition in the family of antifungal agents. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF